Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Combined Modality TherapyHematologic NeoplasmsBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideLeukocytes, MononuclearAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsHematopoiesisCord Blood Stem Cell TransplantationCytarabineHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsTime FactorsSurvival RateWhole-Body IrradiationInfectionLymphoma, T-CellSurvival AnalysisDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeImmunosuppressive AgentsHistocompatibility TestingRecombinant ProteinsT-LymphocytesBlood CellsPrednisoneCarboplatinLeukemia, Myeloid, AcuteBlood Cell CountDexamethasoneTransplantation, IsogeneicCells, CulturedLeukemiaVidarabineFollow-Up StudiesAntineoplastic AgentsImmunophenotypingLymphomaFlow CytometryProspective StudiesCytomegalovirus InfectionsBone Marrow PurgingFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesLymphocytesLymphocyte ActivationAnemia, AplasticAntigens, CDCell SeparationMyelodysplastic SyndromesLymphocyte DepletionBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousLiver TransplantationHLA AntigensBlood DonorsLeukocyte CountMonocytesFetal BloodCyclosporineImmunosuppression